 Bloomberg reported that Guardant Health Inc NASDAQ: GH is reportedly exploring an acquisition of NeoGenomics Inc NASDAQ: NEO, citing people familiar with the matter. Related: Precision Oncology Sales Boost Guardant Health Q2 Topline, Backs FY21 Outlook, Management Updates. 